| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
CCNL1 |
CCNL1, BM-001, UNQ530/PRO1073: Cyclin-L1 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
DOCK2 |
DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
CENTB2 |
CENTB2, KIAA0041: Centaurin-beta 2 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
NACA |
NACA, HSD48: Nascent polypeptide-associated complex subunit alpha |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
ROCK1 |
ROCK1: Rho-associated protein kinase 1 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
0.265 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
MPP6 |
MPP6, VAM1: MAGUK p55 subfamily member 6 |
0.265 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
MAP3K5 |
MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 |
0.265 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
MAP3K14 |
MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 |
0.265 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
MAPK6 |
MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 |
0.265 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
0.265 |
Evidence |
|
| ETV6 |
ETV6, TEL, TEL1: Transcription factor ETV6 |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
| ETV6 |
ETV6, TEL, TEL1: Transcription factor ETV6 |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.265 |
Evidence |
|
| CEACAM6 |
CEACAM6, NCA: Carcinoembryonic antigen-related cell adhesion molecule 6 precurso |
SFTPA2 |
SFTPA2, PSAP, SFTP1, SFTPA: Pulmonary surfactant-associated protein A2 precursor |
0.265 |
Evidence |
|
| ITGAE |
ITGAE: Integrin alpha-E precursor |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.265 |
Evidence |
|
| ITGAE |
ITGAE: Integrin alpha-E precursor |
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
0.265 |
Evidence |
|
| GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
CHD4 |
CHD4: Chromodomain-helicase-DNA-binding protein 4 |
0.265 |
Evidence |
|
| GGCX |
GGCX, GC: Vitamin K-dependent gamma-carboxylase |
TRIM28 |
TRIM28, KAP1, RNF96, TIF1B: Transcription intermediary factor 1-beta |
0.265 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
USP24 |
USP24, KIAA1057: Ubiquitin carboxyl-terminal hydrolase 24 |
0.265 |
Evidence |
|